This Time, Hardly Anyone Followed Trump’s Lead on Virus Drugs
Newly compiled prescription data shows that President Trump’s decision to take an antimalarial drug to ward off the coronavirus did not inspire many Americans to do the same, reflecting the fast-changing landscape surrounding the virus and efforts to treat it. First-time prescriptions ticked up by only several hundred the day after Mr. Trump mentioned at…